Lactate dehydrogenase predicts combined progression‐free survival after sequential therapy with abiraterone and enzalutamide for patients with castration‐resistant prostate cancer
Keiichiro Mori; Takahiro Kimura; Hajime Onuma; Shoji Kimura; Toshihiro Yamamoto; Hiroshi Sasaki; Jun Miki; Kenta Miki; Shin Egawa
Author Information: Department of Urology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.